Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT00439686
PHASE1/PHASE2
Study of ZIO-201 in Advanced Sarcoma
Sponsor: Alaunos Therapeutics
View on ClinicalTrials.gov
Summary
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.
Official title: A Phase IB/IIA Study of the Safety and Activity of Intravenous Isophosphoramide Mustard (ZIO-201) in Patients With Advanced Sarcoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
54
Start Date
2006-02-21
Completion Date
2008-01-16
Last Updated
2026-10-05
Healthy Volunteers
No
Conditions
Interventions
DRUG
ZIO-201
Palifosfamide-lysine (ZIO-201) was administered by intravenous infusion on Days 1, 2, and 3 of each 21-day cycle. Dose and formulation are specified in the corresponding Arm descriptions.
Locations (2)
Santa Monica, California, United States
Ann Arbor, Michigan, United States